Executive Summary: Mass Spectrometry in Protein Biomarker Applications: Software, Services, and Instrument Markets

Containing a snapshot of the overall market analysis, each Executive Summary provides a description of the scope and methodology used in the report; a summary of results including market size and market growth; a sampling of charts and graphs when available; and a brief look at the trends shaping the market.

The report from which this Executive Summary is compiled is Mass Spectrometry in Protein Biomarker Applications: Software, Services, and Instrument Markets, and the full study abstract is as follows:

Protein biomarkers have become the hot application area for mass spectrometry (MS) and other proteomics-related technologies in the last few years. In the short term, this move towards biomarkers and clinical proteomics research has happened mainly in the drug discovery and development process. However, they also have broad abilities to generate richer information about a disease state, drug response, and/ or the relation between the two; which can be used for diagnostic, prognostic, or various other purposes in the pharmaceutical, diagnostics, and defense industries.

MS has the necessary abilities to rapidly identify biochemicals such as DNA, proteins, or carbohydrates, and thus is currently being used as the workhorse for discovering and validating biomarkers in clinical research, whether for drug development, diagnostic, or other applications. MS technology also far outperforms any alternative for this purpose, due to its particular ability to identify large numbers of components in complex mixtures. These increased abilities have drawn large numbers of life science researchers to procure MS instruments or use available core lab facilities for proteomics experiments.

This report focuses on MS technologies as they are applied to protein biomarker research. It provides in-depth analysis of the markets for:

• MS Instrumentation,
• MS Software, and
• MS Services